Your browser doesn't support javascript.
loading
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.
Lavelle, Tara A; Feng, Xue; Keisler, Marlena; Cohen, Joshua T; Neumann, Peter J; Prichard, Daryl; Schroeder, Brock E; Salyakina, Daria; Espinal, Paula S; Weidner, Samuel B; Maron, Jill L.
  • Lavelle TA; Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA. Electronic address: tlavelle@tuftsmedicalcenter.org.
  • Feng X; Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA.
  • Keisler M; Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA.
  • Cohen JT; Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA.
  • Neumann PJ; Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA.
  • Prichard D; Personalized Medicine Coalition, Washington, DC.
  • Schroeder BE; Illumina, San Diego, CA.
  • Salyakina D; Personalized Medicine and Health Outcomes Research, Nicklaus Children's Hospital, Miami, FL.
  • Espinal PS; Personalized Medicine and Health Outcomes Research, Nicklaus Children's Hospital, Miami, FL.
  • Weidner SB; Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA.
  • Maron JL; Women & Infants Hospital of Rhode Island, Care New England Health System, Providence, RI.
Genet Med ; 24(6): 1349-1361, 2022 06.
Article en En | MEDLINE | ID: mdl-35396982

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Exoma Tipo de estudio: Health_economic_evaluation Límite: Child / Humans / Infant Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Exoma Tipo de estudio: Health_economic_evaluation Límite: Child / Humans / Infant Idioma: En Año: 2022 Tipo del documento: Article